Neo-Synephrine Allergo is indicated for the prevention and treatment of perennial and seasonal allergic rhinitis with previous medical diagnosis in patients over 18 years of age .
Active substances: 50µg of beclomethasone dipropionate.
Beclomethasone dipropionate has a potent anti-inflammatory and vasoconstrictor effect.
Dosage and method of administration:
Nasal route. The dose should be the lowest dose at which effective symptom control is achieved. Adults and youth over the age of 18: As a non-pressurized spray, the recommended dose is two applications in each nostril twice a day or, if you prefer, one application in each nostril three to four times a day . Total daily administration should normally not exceed 8 applications (400 µg). The maximum dose per nostril is 100µg and the maximum daily dose per nostril is 200µg. Neo-Synephrine Alergo should not be used for longer than 3 months without medical advice. For full therapeutic benefit, regular administration is essential. Patient compliance should be sought for regular administration and explained that maximum relief may not be achieved with the first few applications. You should consult your doctor if symptoms persist after 14 days of treatment.
Hypersensitivity to the active substance(s) or to any of the excipients.
If in doubt or if symptoms persist, consult your doctor or pharmacist.
In accordance with current legislation, non-prescription medicines in Portugal can only be delivered to the municipalities of Maia, Gondomar, Matosinhos, Porto, Santo Tirso, Trofa, Valongo and Vila do Conde. This limitation does not apply to shipments to other Member States of the European Union.